MRI-based kidney volume measurements in ADPKD: Reliability and effect of gadolinium enhancement

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 4, 2009, Pages 719-725

  Bae, Kyongtae T ^a   Tao, Cheng ^a   Zhu, Fang ^a   Bost, James E ^a   Chapman, Arlene B ^b   Grantham, Jared J ^c   Torres, Vicente E ^d   Guay Woodford, Lisa M ^e   Meyers, Catherine M ^f   Bennett, William M ^g  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^g Northwest Renal Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HUMAN; IMAGE ANALYSIS; KIDNEY POLYCYSTIC DISEASE; KIDNEY SIZE; MALE; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; RELIABILITY; COMPARATIVE STUDY; DATA BASE; EVALUATION; IMAGE ENHANCEMENT; KIDNEY; MIDDLE AGED; OBSERVER VARIATION; ORGAN SIZE; PATHOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; REPRODUCIBILITY; THREE DIMENSIONAL IMAGING;

ADOLESCENT; ADULT; CONTRAST MEDIA; DATABASES AS TOPIC; FEMALE; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; KIDNEY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; ORGAN SIZE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 66449117932     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03750708     Document Type: Article

References (33)

1. Gabow PA: Autosomal dominant polycystic kidney disease. N Engl J Med 329: 332-342, 1993
2. Wilson PD: Polycystic kidney disease. N Engl J Med 350: 151-164, 2004
3. Choukroun G, Itakura Y, Man NK, Christophe JL, Albouze G, Jungers P, Grünfeld JP: The rate of progression of renal failure in ADPKD. Contrib Nephrol 115: 28-32, 1995
4. Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH: Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41: 1311-1319, 1992
5. Grantham JJ: Mechanisms of progression in autosomal dominant polycystic kidney disease. Kidney Int Suppl 63: S93-97, 1997
6. Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF Jr, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP; CRISP Investigators: Volume progression in polycystic kidney disease. N Engl J Med 354: 2122-2130, 2006
7. Bae KT, Commean PK, Lee J: Volumetric measurement of renal cysts and parenchyma using MRI: Phantoms and patients with polycystic kidney disease. J Comput Assisted Tomogr 24: 614-619, 2000
8. Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, Kenney PJ, King BF Jr, Glockner JF, Wetzel LH, Brummer ME, O'Neill WC, Robbin ML, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.: Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int 64: 1035-1045, 2003
9. Bae KT, Zhu F, Chapman AB, Torres VE, Grantham JJ, Guay-Woodford LM, Baumgarten DA, King BF Jr, Wetzel LH, Kenney PJ, Brummer ME, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP): Magn Reson Imaging Evaluation of Hepatic Cysts in Early Autosomal-Dominant Polycystic Kidney Disease: The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease Cohort. Clin J Am Soc Nephrol 1: 64-69, 2006
10. Thomsen HS, Marckmann P: Extracellular Gd-CA: differences in prevalence of NSF. European journal of radiology 66: 180-183, 2008
11. Bellin MF, Van Der Molen AJ: Extracellular gadolinium-based contrast media: An overview. European journal of radiology 66: 160-167, 2008
12. Thomsen HS: ESUR guideline: Gadolinium-based contrast media and nephrogenic systemic fibrosis. European radiology 17: 2692-2696, 2007
13. King BF, Torres VE, Brummer ME, Chapman AB, Bae KT, Glockner JF, Arya K, Felmlee JP, Grantham JJ, Guay- Woodford LM, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP): Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease. Kidney Int 64: 2214-2221, 2003
14. Bartsch G: Stereology, a new quantitative morphological approach to study prostatic function and disease. Eur Urol 3: 85-95, 1977 (Pubitemid 8095734)
15. Brugghe J, Baak JP, Meijer GA, van Diest PJ, Brinkhuis M: Rapid and reliable assessment of volume percentage of epithelium in borderline and invasive ovarian tumors. Anal Quant Cytol Histol 20: 14-20, 1998 (Pubitemid 28096059)
16. Doherty CP, Fitzsimons M, Holohan T, Mohamed HB, Farrell M, Meredith GE, Staunton H: Accuracy and validity of stereology as a quantitative method for assessment of human temporal lobe volumes acquired by magnetic resonance imaging. Magn Reson Imaging 18: 1017-1025, 2000
17. Garden AS, Roberts N: Fetal and fetal organ volume estimations with magnetic resonance imaging. Am J Obstet Gynecol 175: 442-448, 1996 (Pubitemid 26391005)
18. Graves MJ, Dommett DM: Comparison of cardiac stroke volume measurement determined using stereological analysis of breath-hold cine MRI and phase contrast velocity mapping. Br J Radiol 73: 825-832, 2000
19. Mazonakis M, Damilakis J, Maris T, Prassopoulos P, Gourtsoyiannis N: Comparison of two volumetric techniques for estimating liver volume using magnetic resonance imaging. J Magn Reson Imaging 15: 557-563, 2002 (Pubitemid 34461551)
20. Ronan L, Doherty CP, Delanty N, Thornton J, Fitzsimons M: Quantitative MRI: A reliable protocol for measurement of cerebral gyrification using stereology. Magn Reson Imaging 24: 265-272, 2006
21. Walton JM, Roberts N, Whitehouse GH: Measurement of the quadriceps femoris muscle using magnetic resonance and ultrasound imaging. Br J Sports Med 31: 59-64, 1997 (Pubitemid 27110623)
22. Dalgaard OZ: Bilateral polycystic disease of the kidneys: A follow-up of two hundred eighty-four patients and their families. Acta Med Scand 328(suppl): 1-233, 1957
23. Gabow PA, Chapman AB, Johnson AM, Tangel DJ, Duley IT, Kaehny WD, Manco-Johnson M, Schrier RW: Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int 38: 1177-1180, 1990
24. Fick-Brosnahan GM, Belz MM, McFann KK, Johnson AM, Schrier RW: Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: A longitudinal study. Am J Kidney Dis 39: 1127-1134, 2002
25. Parfrey PS, Bear JC, Morgan J, Cramer BC, McManamon PJ, Gault MH, Churchill DN, Singh M, Hewitt R, Somlo S, et al.: The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med 323: 1085-1090, 1990 (Pubitemid 20370728)
26. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid- Smith P, Danks DM: Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343: 824-827, 1994 (Pubitemid 24147512)
27. Gabow PA, Ikle DW, Holmes JH: Polycystic kidney disease: Prospective analysis of nonazotemic patients and family members. Ann Intern Med 101: 238-247, 1984
28. Gabow PA, Kaehny WD, Johnson AM, Duley IT, Manco- Johnson M, Lezotte DC, Schrier RW: The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int 35: 675-680, 1989 (Pubitemid 19051769)
29. Thomsen HS, Madsen JK, Thaysen JH, Damgaard-Petersen K: Volume of polycystic kidneys during reduction of renal function. Urol Radiol 3: 85-89, 1981
30. King BF, Reed JE, Bergstralh EJ, Sheedy PF 2nd, Torres VE: Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 11: 1505-1511, 2000
31. Thomsen HS: How to avoid CIN: Guidelines from the European Society of Urogenital Radiology. Nephrol Dial Transplant 20 Suppl 1: i18 -22, 2005
32. Thomsen HS, Marckmann P: MRI contrast media are used to improve visualization of abnormal structures or lesions in various parts of the body. Introduction. Eur J Radiol 66:153-159, 2008
33. Bass JC, Prince MR, Londy FJ, Chenevert TL: Effect of gadolinium on phase-contrast MR angiography of the renal arteries. AJR 168: 261-266, 1997